CALIFORNIA MEDICAL ASSOCIATION INC. lobbying for CALIFORNIA MEDICAL ASSOCIATION INC

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Expenses

$40,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Medicare/Medicaid

H.R. 8163: Provider Reimbursement Stability Act of 2026; provisions related to Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) budget neutrality H.R. 9693: Patients First Act of 2026; all provisions S. 5180: Provider Reimbursement Stability Act of 2026 ; all provisions CMS-1848-P: Medicare Physician Payment Rule; all provisions CMS-2449-P: Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-For-Service Targeted Medicaid Practitioner Payments; all provisions CMS-2452-P: Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes; all provisions

Health Issues

H.R. 3164: Ensuring Community Access to Pharmacist Services Act; all provisions H.R. 3514: Improving Seniors' Timely Access to Care Act of 2025; all provisions H.R. 4710: No Surprises Act Enforcement Act; all provisions H.R. 6160: Strengthening Medicare for Patients and Providers Act; provisions related to Medicare physician payments S. 1816: Improving Seniors Timely Access to Care Act of 2025; all provisions S. 2420: No Surprise Act Enforcement Act; all provisions HHS-OS-2026-0332-0001: Categories Used in Federal Vaccine Recommendations and the Roles of Shared Clinical Decision-Making; all provisions

Government Issues

OMB-2026-0034: Proposed Revisions to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards; all provisions

Medical/Disease Research/Clinical Labs

OMB-2026-0034: Proposed Revisions to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards; all provisions

Bills named in this filing 9

H.R. 8163
Provider Reimbursement Stability Act of 2026
H.R. 9693
Patients First Act of 2026
S. 5180
Provider Reimbursement Stability Act of 2026
H.R. 3164
Ensuring Community Access to Pharmacist Services Act
H.R. 3514
Improving Seniors’ Timely Access to Care Act of 2025
H.R. 4710
No Surprises Act Enforcement Act
H.R. 6160
Strengthening Medicare for Patients and Providers Act
S. 1816
Improving Seniors’ Timely Access to Care Act of 2025
S. 2420
No Surprises Act Enforcement Act